Blog
RSS FeedPosted by Michael Wonder on 08 Dec 2016
First stage of prostheses benefit reform commences
6 December 2016 - The Department of Health has commenced work to reform prostheses benefits, with a research and design ...
Posted by Michael Wonder on 08 Dec 2016
Single drug technology assessment processes across Health Technology Assessment organisations
8 December 2016 - Health Technology Assessment (HTA) informs health care decision-makers about the value — such as the safety, efficacy, ...
Posted by Michael Wonder on 08 Dec 2016
Decision regarding PHARMAC’s implementation of Trans-Pacific Partnership provisions and other amendments to application processes
8 December 2016 - PHARMAC is pleased to announce that changes will be made to its Operating Policies and Procedures ...
Posted by Michael Wonder on 07 Dec 2016
Review of pharmacy remuneration and regulation - pharmacy financial survey update
7 December 2016 - In response to concerns amongst some pharmacy owners regarding the intended purpose of the Review’s Pharmacy ...
Posted by Michael Wonder on 06 Dec 2016
Heartless' to deny breast cancer drug
5 December 2016 - The Breast Cancer Foundation is demanding approval granted for a new drug be extended to those already ...
Posted by Michael Wonder on 06 Dec 2016
Foreign visa holders leaving millions in hospital debts
7 December 2016 - Foreign students and 457 visa holders are leaving behind millions of dollars in unpaid hospital bills ...
Posted by Michael Wonder on 06 Dec 2016
Considerable additional benefit of Eisai's Halaven (eribulin mesylate) in advanced liposarcoma confirmed by the German Federal Joint Committee
4 December 2016 - Eribulin mesylate has shown unprecedented survival benefit in advanced liposarcoma in pivotal phase III trial. ...
Posted by Michael Wonder on 06 Dec 2016
Clostridium botulinum type A toxin (Botox) in DHB hospitals
6 December 2016 - PHARMAC is seeking feedback on a proposal to amend the contractual terms of listing for clostridium botulinum ...
Posted by Michael Wonder on 05 Dec 2016
Company brings unapproved life saving drugs to Australia. But is it medicine for the rich?
5 December 2016 - When the cancer in Karen Cowley's breast spread to her spine and brain, and her current ...
Posted by Michael Wonder on 05 Dec 2016
Private health fund members stuck with outdated treatments due to ‘loophole’
5 December 2016 - Privately insured Australians are missing out on life saving treatments for strokes, heart problems and blocked ...
Posted by Michael Wonder on 05 Dec 2016
Can the government really protect your privacy when it 'de-identifies' public data?
5 December 2016 - We don't yet know to how to use big data and protect privacy at the same time. ...
Posted by Michael Wonder on 05 Dec 2016
PHARMAC funds breast cancer drug Perjeta
5 December 2016 - More breast cancer sufferers will soon have access to a treatment programme that can extend lives ...
Posted by Michael Wonder on 05 Dec 2016
Online booking tool could be the key to sweeping public health reforms
5 December 2016 - Patients wanting knee replacements or skin cancers removed could use an online booking tool to pick ...
Posted by Michael Wonder on 05 Dec 2016
Hepatitis C drugs Australia's most expensive, cost taxpayers $1 billion in four months
5 December 2016 - Hepatitis C medications approved in March this year have already topped the list of Australia's most ...
Posted by Michael Wonder on 04 Dec 2016
Approval of multi-product funding proposal with Roche
5 December 2016 - PHARMAC is pleased to announce a major funding package following an agreement with Roche for funding ...